Drugs Made In America Acquisition Corp. - Units (DMAAU)
NASDAQ: DMAAUFinancial ServicesShell CompaniesUSD
At close: Sep 21, 4:00 PM ET · Delayed 15 min
DMAAU stock chart
Technical analysisKey statistics
All statistics- Dividend yield
- None
- 52-week range
- 10.30 – 12.50
- Day range
- 10.79 – 10.79
- Volume / Avg
- 25 / 25
- Beta
- —
- Shares outstanding
- 29.17M
52-week range
DMAAU stock today
Drugs Made In America Acquisition - Units (DMAAU) last traded at $10.79 on Sep 21. At this level, DMAAU sits in the middle of its 52-week range of $10.30 to $12.50: 13.7% below the high, set on May 22, 2026 and 4.8% above the low. DMAAU is up 4.8% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has gained 4.3%.
Summary generated from market data by MetaCap's automated system. Methodology
About Drugs Made In America Acquisition - Units
Company profileDrugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses.
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Roger Bendelac
- Headquarters
- New York, NY
- IPO year
- 2025
Drugs Made In America Acquisition - Units peers
Financial Services sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ALISUCalisa Acquisition Corp Units | 40.00 | +140.24% | — | vs DMAAU |
| ALDFUAldel Financial II Inc. - Units | 10.90 | 0.00% | — | vs DMAAU |
| BLUWUBlue Water Acquisition Corp. III - Unit. | 10.50 | 0.00% | — | vs DMAAU |
| AMACUAMR Resources Acquisition Corp - Units | 9.90 | -0.20% | — | vs DMAAU |
| PGACUPantages Capital Acquisition Corporation Unit | 10.89 | -1.89% | — | vs DMAAU |
| CHARUCharlton Aria Acquisition Corporation Units | 11.30 | -0.96% | — | vs DMAAU |
| ARTCUArt Technology Acquisition Corp. - Units | 10.15 | +0.59% | — | vs DMAAU |
| AACOUAbony Acquisition Corp. I - Units | 10.10 | 0.00% | — | vs DMAAU |
Indexes, lists and sector
Largest Financial Services stocks
Drugs Made In America Acquisition - Units stock FAQ
What is Drugs Made In America Acquisition - Units's stock price today?
DMAAU last traded at $10.79 as of Sep 21, 4:00 PM EDT, up 0.00% on the day. Prices are delayed at least 15 minutes.
Who is Drugs Made In America Acquisition - Units's CEO?
Mr. Roger Bendelac is the chief executive officer of Drugs Made In America Acquisition Corp. - Units.
What is the DMAAU 52-week high?
The 52-week high for DMAAU is $12.50 and the 52-week low is $10.30. The stock is currently 13.7% below its high.